Italy has recently enacted its own “Artificial Intelligence Act”, set to take effect on October 10, 2025.

You might be wondering: Did we really need another layer of AI regulation? That was our initial reaction, too. But a closer look reveals that the Italian AI Law introduces several interesting provisions, especially in the healthcare sector, that could facilitate research for both public and private entities. Here are some highlights:

1. Healthcare Data Processing as Based on Public Interest

The law explicitly recognizes that the processing of health-related personal data by:

• Public or private non-profit entities,
• Research hospitals (IRCCS),
• Private entities collaborating with the above for healthcare research,

is of “substantial public interest.” This significantly expands the scope of Article 9(2)(g) of the GDPR, offering a clearer legal basis for processing sensitive data in research contexts.

2. Secondary Use of Data

The law introduces a simplified regime for the secondary use of personal data without direct identifiers. In particular:

• No new consent required, as long as data subjects are informed (even via a website).
• Automatic authorization unless blocked by the Data Protection Authority within 30 days of notification.

This provision applies only to the entities mentioned above so it is limited in scope, but in any case significantly strengthens the framework for nonprofit research projects.

3. Freedom to Anonymize, Pseudonymize and Synthesize

Under Article 8(4) of the AI Law, processing data for anonymization, pseudonymization, or synthesization is always permitted, provided the data subject is informed. This is a major step forward in enabling privacy-preserving AI research.

4. Guidelines and Governance

The law delegates the creation of technical guidelines to:

• AGENAS – for anonymization and synthetic data generation.
• Ministry of Health – for processing health data in research, including AI applications.

It also establishes a national AI platform at AGENAS, which will act as the data controller for personal data collected and generated within the platform.

Final Thoughts

While the GDPR aimed to support research, its implementation often created legal uncertainty and operational hurdles. Italy’s AI Law appears to address some of these gaps, offering a more pragmatic and enabling framework for healthcare research.